123I Radiolabeled 3BNC117
NCT03468582
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Human Immunodeficiency Virus
Interventions
COMBINATION_PRODUCT:
123I radiolabeled 3BNC117
Sponsor
University of Lausanne Hospitals